Castle Biosciences (CSTL) Amortizatization of Intangibles (2022 - 2026)

Castle Biosciences has reported Amortizatization of Intangibles for 5 years, with the latest figure at $392000.0 in Q2 2026.

• Quarterly Amortizatization of Intangibles fell 66.52% year-over-year to $392000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.5 million (down 58.1% YoY) and the FY2025 annual result came in at $4.2 million, down 36.89% from the prior year.
• Amortizatization of Intangibles retreated to $392000.0 in Q2 2026 per CSTL's latest filing, from $454000.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $1.7 million in Q2 2024 and troughed at $184000.0 in Q3 2022.
• A 5-year average of $1.2 million and a median of $1.2 million in 2022 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles soared 752.72% in 2023, then slumped 68.36% in 2026.
• Over 5 years, Amortizatization of Intangibles stood at $1.2 million in 2022, then soared by 38.51% to $1.6 million in 2023, then slipped by 1.65% to $1.6 million in 2024, then slumped by 56.11% to $708000.0 in 2025, then slumped by 44.63% to $392000.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $392000.0, $454000.0, and $708000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.